---
layout: post
title: "Data Standards for Drug and Biological Product Submissions Containing Real-World Data; Guidance for Industry; Availability"
date: 2026-02-05 18:58:04 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-28291
original_published: 2023-12-22 00:00:00 +0000
significance: 8.00
---

# Data Standards for Drug and Biological Product Submissions Containing Real-World Data; Guidance for Industry; Availability

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** December 22, 2023 00:00 UTC
**Document Number:** 2023-28291

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Data Standards for Drug and Biological Product Submissions Containing Real- World Data." This guidance provides recommendations to sponsors to help support compliance with the Federal Food, Drug, and Cosmetic Act (FD&C Act) when submitting study data derived from real-world data (RWD) sources in applicable regulatory submissions using standards specified in the Data Standards Catalog. FDA is publishing this guidance as part of a series of guidance documents under its program to evaluate the use of real-world evidence (RWE) in regulatory decision making. This guidance finalizes the draft guidance of the same title issued on October 22, 2021.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/12/22/2023-28291/data-standards-for-drug-and-biological-product-submissions-containing-real-world-data-guidance-for)
- API: https://www.federalregister.gov/api/v1/documents/2023-28291

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
